UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2023 Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q1 2023 Earnings Call Transcript May 11, 2023

UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-1.3, expectations were $-1.33.

Operator: Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the UroGen Pharma Q1 2023 Earnings Call. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Vincent Perrone. Head Investor Relations. You may...